AI-generated summary
The authors conducted a network meta-analysis of 34 studies (35 randomized trials, 1,559 participants) comparing photobiomodulation, tDCS and rTMS in Alzheimer's disease. All three improved global cognition versus control, with photobiomodulation showing the largest estimated effects, though indirect comparisons with rTMS were not uniformly significant. The authors note the need for large-scale trials.
- Participants
- 1,559
- Studies included
- 34
- Who or what was studied
- Adults with Alzheimer's disease
- Limits stated in the abstract
- The abstract reports only indirect comparisons for some outcomes, with one MMSE comparison narrowly missing statistical significance, and calls for large-scale randomized trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Transcranial direct current stimulation, Transcranial magnetic stimulation, Meta-analysis, Statistical significance, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.